<DOC>
	<DOCNO>NCT00487929</DOCNO>
	<brief_summary>The purpose study compare level 8-isoprostane oxidative stress biomarkers plasma condense exhaled air patient SAHS cardiovascular complication , patient SAHS without cardiovascular complication control subject . To evaluate effect three month treatment CPAP oxidative stress biomarkers .</brief_summary>
	<brief_title>Oxidative Stress Cardiovascular Morbidity Sleep Apnea-Hypopnea Syndrome ( SAHS )</brief_title>
	<detailed_description>Aim : To compare level 8-isoprostane oxidative stress biomarkers plasma condense exhaled air patient SAHS cardiovascular complication , patient SAHS without cardiovascular complication control subject . To evaluate effect three month treatment CPAP oxidative stress biomarkers . Design : randomize , double blind , parallel group control placebo study . Study subject : 53 patient SAHS ( 23 cardiovascular complication 30 without cardiovascular complication ) , 23 patient cardiovascular disease without SAHS 23 control subject . Interventions : Three month treatment therapeutic CPAP sham CPAP ( placebo ) . Determinations : clinical ( cardiovascular morbidity ) anthropometric data . Fat free corporal mass , echocardiography , spirometry , ambulatory monitoring arterial pressure , endothelial reactivity . Oxidative stress biomarkers ( 8-isoprostane , homocysteine , HIF-1 , NFkB , AP-1 , VEGF , ET-1 , TNF-alpha , IL-1 , IL-6 , ICAM-1 , VCAM-1 , nitrate nitrite ) plasma condense exhaled air.Peripheral sensitivity hypoxia . Urinary excretion catecholamine .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Sleep apneahypopnea syndrome ( AHI &gt; 5 ) Excessive sleepiness ( ESS &gt; 11 ) No previous CPAP treatment Blood pressure &gt; 180/120 mmHg . Secondary hypertension Professional driver COPD , asthma , bronchiectasis , lung cancer , restrictive lung disorder , chest wall disease Neuromuscular disease thyroid function abnormality Morbid obesity ( BMI &gt; 40 Kg/m2 ) . Respiratory infection 2 last month . Anemia ( Hb &lt; 10 g/dl ) polyglobulia ( Hct &gt; 55 % ) . Diurnal hypercapnia ( PaCO2 &gt; 45 mmHg ) moderate hypoxemia ( PaO2 &lt; 70 mmHg ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>sleep apnea</keyword>
	<keyword>morbidity</keyword>
	<keyword>cardiovascular</keyword>
	<keyword>cpap</keyword>
	<keyword>oxidative stress</keyword>
</DOC>